Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,941 | 15,644 | 14,938 | 8,427 | 19,175 |
| Marketable Securities | 7,180 | 11,094 | 16,308 | 19,059 | 23,841 |
| TOTAL | $27,140 | $29,221 | $33,660 | $30,654 | $46,359 |
| Non-Current Assets | |||||
| PPE Net | 150 | 315 | 349 | 383 | 350 |
| Intangibles | 120 | 120 | 120 | 120 | 120 |
| Other Non-Current Assets | 100 | 145 | 189 | 189 | 189 |
| TOTAL | $370 | $580 | $658 | $692 | $659 |
| Total Assets | $27,510 | $29,801 | $34,318 | $31,346 | $47,018 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 872 | 944 | 1,935 | 2,067 | 3,049 |
| Accrued Expenses | 1,244 | 1,676 | 2,261 | 1,844 | 3,601 |
| TOTAL | $2,116 | $2,620 | $4,196 | $3,911 | $6,650 |
| Non-Current Liabilities | |||||
| TOTAL | $33 | $76 | $88 | $97 | $106 |
| Total Liabilities | $2,149 | $2,696 | $4,284 | $4,008 | $6,756 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,486 | 39,181 | 25,860 | 18,891 | 18,873 |
| Common Shares | 4 | 29 | 25 | 19 | 2 |
| Retained earnings | -141,240 | -133,758 | -126,180 | -116,374 | -102,398 |
| Other shareholders' equity | -7 | 11 | 18 | 26 | -17 |
| TOTAL | $25,361 | $27,105 | $30,034 | $27,338 | $40,262 |
| Total Liabilities And Equity | $27,510 | $29,801 | $34,318 | $31,346 | $47,018 |